Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03702842 · ClinicalTrials.gov registry record · NA

Stimulation to Enhance Walking Post-SCI

A NA study of SCI - Spinal Cord Injury and Incomplete Spinal Cord Injury, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT03702842: Completed NA study of SCI - Spinal Cord Injury and Incomplete Spinal Cord Injury, sponsored by University of Florida.

NCT03702842 is a NA study of SCI - Spinal Cord Injury and Incomplete Spinal Cord Injury that has completed, run by University of Florida. The registered enrollment target is 8 participants, below the 37-participant average among 13 other SCI - Spinal Cord Injury trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03702842, a NA study of SCI - Spinal Cord Injury and Incomplete Spinal Cord Injury, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

This pilot study will investigate the effects of transcutaneous direct current stimulation (tsDCS) on walking function in individuals with incomplete spinal cord injury. Following rehabilitation, individuals with ISCI often demonstrate improved walking function, but continue to have serious impairments that limit mobility, community participation and quality of life. Adjuvants to rehabilitation that increase spinal excitation during training may enhance its effectiveness. tsDCS is a non-invasive neuromodulation approach that uses a mild electrical current, applied over the skin of the low back, to alter the membrane potential of spinal neurons. tsDCS will be applied during locomotor training, a well-established rehabilitation strategy that promotes walking recovery. Locomotor training emphasizes repetitive and task-specific practice of coordinated walking, often with therapist assistance or cueing to promote high quality movement patterns. The study team will explore if tsDCS combined with locomotor training increases spinal excitation and thereby improves the effectiveness of walking rehabilitation.

Primary Outcome

Performance assessment of comfortable and fastest safe walking speed for 10 meters. A reduced time (in seconds) to complete the 10-Meter Walk Test reflects improvement in walking function.

Interventions

  • DEVICE Soterix Medical tsDCS stimulator
  • OTHER Locomotor training

Study Locations (1)

Florida

  • Brooks Rehabilitation Hospital - Jacksonville

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2019-04-01
Est. Completion 2022-09-05
Phase NA
University of Florida

1,106 total trials

What the finished NCT03702842 record still lists

NCT03702842 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 37-participant average among 13 other SCI - Spinal Cord Injury trials with a reported enrollment target (78% lower).

The record links to 2 conditions, with SCI - Spinal Cord Injury appearing as the primary indexed condition, and to 2 interventions - of which Soterix Medical tsDCS stimulator is the first listed.

NCT03702842 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT03702842 about?

NCT03702842 is a clinical study titled "Stimulation to Enhance Walking Post-SCI". This pilot study will investigate the effects of transcutaneous direct current stimulation (tsDCS) on walking function in individuals with incomplete spinal cord injury. Following rehabilitation, individuals with ISCI often demonstrate improved walking function, but continue to have serious impairme...

What is the current status of trial NCT03702842?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2019-04-01. Estimated completion is 2022-09-05.

What conditions does trial NCT03702842 study?

This clinical trial studies the following conditions: SCI - Spinal Cord Injury, Incomplete Spinal Cord Injury.

What interventions are being tested in trial NCT03702842?

The interventions under investigation include: Soterix Medical tsDCS stimulator (DEVICE), Locomotor training (OTHER).

Who is sponsoring clinical trial NCT03702842?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03702842 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for SCI - Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03702842's enrollment target sits among peer trials

8 13th of 13 higher than 1 of 13 other SCI - Spinal Cord Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other SCI - Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03702842, the US trial registry maintained by the National Library of Medicine. NCT03702842 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.